Cato T. Laurencin - Dec 8, 2024 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
Director
Signature
/s/ Shantale Greenson, attorney-in-fact for Cato T. Laurencin
Stock symbol
ALKS
Transactions as of
Dec 8, 2024
Transactions value $
-$55,246
Form type
4
Date filed
12/9/2024, 08:51 PM
Previous filing
Jul 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Options Exercise +4.16K +21.02% 24K Dec 8, 2024 Direct F1
transaction ALKS Ordinary Shares Tax liability -$30.1K -958 -4% $31.46 23K Dec 8, 2024 Direct
transaction ALKS Ordinary Shares Options Exercise $60.6K +2.69K +11.69% $22.52 25.7K Dec 9, 2024 Direct F2
transaction ALKS Ordinary Shares Sale -$85.7K -2.69K -10.47% $31.85 23K Dec 9, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Restricted Stock Unit Award Options Exercise -4.16K -100% 0 Dec 8, 2024 Ordinary Shares 4.16K Direct F1, F4
transaction ALKS Non Qualified Stock Option (Right to Buy) Options Exercise $0 -2.69K -14.29% $0.00 16.1K Dec 9, 2024 Ordinary Shares 2.69K $22.52 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share.
F2 This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2023.
F3 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2023.
F4 This award is fully vested in accordance with its terms.
F5 These options are fully vested in accordance with their terms.